ArticleBMC cancer2021

TRAIL-coated leukocytes to kill circulating tumor cells in the flowing blood from prostate cancer patients.

Nerymar Ortiz-Otero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.